Paper42453508
Development and validation of a predictive model for diabetic kidney disease risk in patients with T2DM: a hospital data platform study.
Zhang Z and 9 others. Front Endocrinol (Lausanne), 2026. Cited by 0 papers, by iCite.
Cite this record
ConductScience Library. Development and validation of a predictive model for diabetic kidney disease risk in patients with T2DM: a hospital data platform study. Papers, record 42453508. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42453508
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Development and validation of a predictive model for diabetic kidney disease risk in patients with T2DM: a hospital data platform study.
- PubMed
Topics13
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Diabetes Mellitus, Type 2 | Major topic |
| Diabetic Nephropathies | Major topic |
| Nomograms | Major topic |
| Humans | |
| Female | |
| Retrospective Studies | |
| Risk Factors | |
| Middle Aged | |
| Male | |
| Prediction Algorithms | |
| ROC Curve | |
| Aged | |
| Risk Assessment |
Source PubMed
References43
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 41412135 | 11th edition of the IDF Diabetes Atlas: global, regional, and national diabetes prevalence estimates for 2024 and projections for 2050. | Lancet Diabetes Endocrinol | 2026 | https://conductscience.org/library/papers/41412135 | PubMed |
| 2 | 39806549 | Trends and analysis of risk factor differences in the global burden of chronic kidney disease due to type 2 diabetes from 1990 to 2021: A population-based study. | Diabetes Obes Metab | 2025 | https://conductscience.org/library/papers/39806549 | PubMed |
| 3 | 32095345 | Development and validation of a predictive model for end-stage renal disease risk in patients with diabetic nephropathy confirmed by renal biopsy. | PeerJ | 2020 | https://conductscience.org/library/papers/32095345 | PubMed |
| 4 | 38746045 | Machine Learning-Based Predictive Modeling of Diabetic Nephropathy in Type 2 Diabetes Using Integrated Biomarkers: A Single-Center Retrospective Study. | Diabetes Metab Syndr Obes | 2024 | https://conductscience.org/library/papers/38746045 | PubMed |
| 5 | 41585789 | Emerging technologies for early risk stratification and precision management of diabetic kidney disease: a multimodal framework integrating digital phenotypes and clinical biomarkers. | Front Endocrinol (Lausanne) | 2025 | https://conductscience.org/library/papers/41585789 | PubMed |
| 6 | 39337706 | Novel Insights into Diabetic Kidney Disease. | Int J Mol Sci | 2024 | https://conductscience.org/library/papers/39337706 | PubMed |
| 7 | 36523225 | External validation of the risk prediction model for early diabetic kidney disease in Taiwan population: a retrospective cohort study. | BMJ Open | 2022 | https://conductscience.org/library/papers/36523225 | PubMed |
| 8 | 36890275 | Effects of Uric Acid-Lowering Therapy on the Kidney (HTR-2023-0096.R2). | Hypertens Res | 2023 | https://conductscience.org/library/papers/36890275 | PubMed |
| 9 | 34962526 | Prevalence and Treatment of Diabetes in China, 2013-2018. | JAMA | 2021 | https://conductscience.org/library/papers/34962526 | PubMed |
| 10 | 39579774 | Diabetes in China part 1: epidemiology and risk factors. | Lancet Public Health | 2024 | https://conductscience.org/library/papers/39579774 | PubMed |
| 11 | 34642880 | Prevention of kidney function decline using uric acid-lowering therapy in chronic kidney disease patients: a systematic review and network meta-analysis. | Clin Rheumatol | 2022 | https://conductscience.org/library/papers/34642880 | PubMed |
| 12 | 36384320 | Regularization approaches in clinical biostatistics: A review of methods and their applications. | Stat Methods Med Res | 2023 | https://conductscience.org/library/papers/36384320 | PubMed |
| 13 | 38374967 | Dose-response association of diabetic kidney disease with routine clinical parameters in patients with type 2 diabetes mellitus: a systematic review and meta-analysis. | EClinicalMedicine | 2024 | https://conductscience.org/library/papers/38374967 | PubMed |
| 14 | 30927104 | Identification of clinical predictors of diabetic nephropathy and non-diabetic renal disease in Chinese patients with type 2 diabetes, with reference to disease course and outcome. | Acta Diabetol | 2019 | https://conductscience.org/library/papers/30927104 | PubMed |
| 15 | 40012233 | Causal insights into major risk factors for diabetic kidney disease: a comprehensive meta-analysis and Mendelian randomization study. | Ren Fail | 2025 | https://conductscience.org/library/papers/40012233 | PubMed |
| 16 | 40600445 | Multi-modal models using fMRI, urine and serum biomarkers for classification and risk prognosis in diabetic kidney disease. | Diabetes Obes Metab | 2025 | https://conductscience.org/library/papers/40600445 | PubMed |
| 17 | 41669246 | A meta-analysis of serum uric acid and diabetic nephropathy risk in type 2 diabetes. | Front Endocrinol (Lausanne) | 2025 | https://conductscience.org/library/papers/41669246 | PubMed |
| 18 | 41685239 | Machine learning model based on routine blood and biochemical parameters for early diagnosis of diabetic kidney disease. | Front Endocrinol (Lausanne) | 2026 | https://conductscience.org/library/papers/41685239 | PubMed |
| 19 | 35864124 | A simplified prediction model for end-stage kidney disease in patients with diabetes. | Sci Rep | 2022 | https://conductscience.org/library/papers/35864124 | PubMed |
| 20 | 38230268 | A Retrospective Study on Predicting Recurrence of Intermediate-Stage Hepatocellular Carcinoma After Radical Therapy. | J Hepatocell Carcinoma | 2024 | https://conductscience.org/library/papers/38230268 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Cited by
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/42453508
GET https://conductscience.org/api/papers/v1/42453508/references?page=2